128 related articles for article (PubMed ID: 32297135)
1. Radiation exposure in nurses during care of
Taniguchi Y; Wakabayashi H; Inaki A; Kayano D; Yamada M; Kinuya S
Ann Nucl Med; 2020 Jun; 34(6):441-447. PubMed ID: 32297135
[TBL] [Abstract][Full Text] [Related]
2. Radiation exposure to family caregivers and nurses of pediatric neuroblastoma patients receiving 131I-metaiodobenzylguanidine (131I-MIBG) therapy.
Markelewicz RJ; Lorenzen WA; Shusterman S; Grant FD; Fahey FH; Treves ST
Clin Nucl Med; 2013 Aug; 38(8):604-7. PubMed ID: 23797228
[TBL] [Abstract][Full Text] [Related]
3. Application of a tungsten apron for occupational radiation exposure in nursing care of children with neuroblastoma during
Taniguchi Y; Wakabayashi H; Yoneyama H; Chen Z; Morino K; Otosaki A; Yamada M; Inaki A; Kayano D; Kinuya S
Sci Rep; 2022 Jan; 12(1):47. PubMed ID: 34996922
[TBL] [Abstract][Full Text] [Related]
4. Pediatric 131I-MIBG Therapy for Neuroblastoma: Whole-Body 131I-MIBG Clearance, Radiation Doses to Patients, Family Caregivers, Medical Staff, and Radiation Safety Measures.
Willegaignon J; Crema KP; Oliveira NC; Pelissoni RA; Coura-Filho GB; Sapienza MT; Buchpiguel CA
Clin Nucl Med; 2018 Aug; 43(8):572-578. PubMed ID: 29916922
[TBL] [Abstract][Full Text] [Related]
5. HIGH-DOSE 131I-MIBG THERAPIES IN CHILDREN: FEASIBILITY, PATIENT DOSIMETRY AND RADIATION EXPOSURE TO WORKERS AND FAMILY CAREGIVERS.
Cougnenc O; Defachelles AS; Carpentier P; Lervat C; Clisant S; Oudoux A; Kolesnikov-Gauthier H
Radiat Prot Dosimetry; 2017 Apr; 173(4):395-404. PubMed ID: 26940442
[TBL] [Abstract][Full Text] [Related]
6. Feasibility of Administering High-Dose (131) I-MIBG Therapy to Children with High-Risk Neuroblastoma Without Lead-Lined Rooms.
Chu BP; Horan C; Basu E; Dauer L; Williamson M; Carrasquillo JA; Pandit-Taskar N; Modak S
Pediatr Blood Cancer; 2016 May; 63(5):801-7. PubMed ID: 26773712
[TBL] [Abstract][Full Text] [Related]
7. Dose escalation study of no-carrier-added 131I-metaiodobenzylguanidine for relapsed or refractory neuroblastoma: new approaches to neuroblastoma therapy consortium trial.
Matthay KK; Weiss B; Villablanca JG; Maris JM; Yanik GA; Dubois SG; Stubbs J; Groshen S; Tsao-Wei D; Hawkins R; Jackson H; Goodarzian F; Daldrup-Link H; Panigrahy A; Towbin A; Shimada H; Barrett J; Lafrance N; Babich J
J Nucl Med; 2012 Jul; 53(7):1155-63. PubMed ID: 22700000
[TBL] [Abstract][Full Text] [Related]
8. Estimated Internal and External Radiation Exposure of Caregivers of Patients With Pediatric Neuroblastoma Undergoing 131I Metaiodobenzylguanidine Therapy: A Prospective Pilot Study.
Han S; Yoo SH; Koh KN; Lee JJ
Clin Nucl Med; 2017 Apr; 42(4):271-274. PubMed ID: 28098666
[TBL] [Abstract][Full Text] [Related]
9. Patient dosimetry after 131I-MIBG therapy for neuroblastoma and carcinoid tumours.
Monsieurs MA; Thierens HM; Vral A; Brans B; De Ridder L; Dierckx RA
Nucl Med Commun; 2001 Apr; 22(4):367-74. PubMed ID: 11338046
[TBL] [Abstract][Full Text] [Related]
10. Iodine-131 metaiodobenzylguanidine (131I-mIBG) treatment in relapsed/refractory neuroblastoma.
Anongpornjossakul Y; Sriwatcharin W; Thamnirat K; Chamroonrat W; Kositwattanarerk A; Utamakul C; Sritara C; Chokesuwattanasakul P; Thokanit NS; Pakakasama S; Anurathapan U; Pongphitcha P; Chotipanich C; Hongeng S
Nucl Med Commun; 2020 Apr; 41(4):336-343. PubMed ID: 31939898
[TBL] [Abstract][Full Text] [Related]
11. High-dose
Kayano D; Wakabayashi H; Nakajima K; Kuroda R; Watanabe S; Inaki A; Toratani A; Akatani N; Yamase T; Kunita Y; Hiromasa T; Takata A; Mori H; Saito S; Araki R; Taki J; Kinuya S
Ann Nucl Med; 2020 Jun; 34(6):397-406. PubMed ID: 32219730
[TBL] [Abstract][Full Text] [Related]
12. Impact of Whole-Body Radiation Dose on Response and Toxicity in Patients With Neuroblastoma After Therapy With 131 I-Metaiodobenzylguanidine (MIBG).
Trieu M; DuBois SG; Pon E; Nardo L; Hawkins RA; Marachelian A; Twist CJ; Park JR; Matthay KK
Pediatr Blood Cancer; 2016 Mar; 63(3):436-42. PubMed ID: 26506090
[TBL] [Abstract][Full Text] [Related]
13. Quantifying the radiation exposure of nursing staff delivering hyperbaric oxygen therapy to grade IV neuroblastoma patients post 131I-MIBG therapy.
Melbourne GJ; Lehm JP
Eur J Nucl Med; 2000 Nov; 27(11):1732-3. PubMed ID: 11105832
[No Abstract] [Full Text] [Related]
14. Correlation of tumor and whole-body dosimetry with tumor response and toxicity in refractory neuroblastoma treated with (131)I-MIBG.
Matthay KK; Panina C; Huberty J; Price D; Glidden DV; Tang HR; Hawkins RA; Veatch J; Hasegawa B
J Nucl Med; 2001 Nov; 42(11):1713-21. PubMed ID: 11696644
[TBL] [Abstract][Full Text] [Related]
15. High-dose
Wakabayashi H; Kayano D; Inaki A; Araki R; Kuroda R; Ikawa Y; Fujiki T; Akatani N; Yamase T; Watanabe S; Hiromasa T; Kunita Y; Mori H; Saito S; Nishimura R; Wada T; Kinuya S
Ann Nucl Med; 2020 Nov; 34(11):840-846. PubMed ID: 32862362
[TBL] [Abstract][Full Text] [Related]
16. Arsenic Trioxide as a Radiation Sensitizer for 131I-Metaiodobenzylguanidine Therapy: Results of a Phase II Study.
Modak S; Zanzonico P; Carrasquillo JA; Kushner BH; Kramer K; Cheung NK; Larson SM; Pandit-Taskar N
J Nucl Med; 2016 Feb; 57(2):231-7. PubMed ID: 26742708
[TBL] [Abstract][Full Text] [Related]
17. Targeted radiotherapy with submyeloablative doses of 131I-MIBG is effective for disease palliation in highly refractory neuroblastoma.
Kang TI; Brophy P; Hickeson M; Heyman S; Evans AE; Charron M; Maris JM
J Pediatr Hematol Oncol; 2003 Oct; 25(10):769-73. PubMed ID: 14528098
[TBL] [Abstract][Full Text] [Related]
18. Letter to the editor.
Kono Y; Shimizu Y; Wakatsuki Y; Yasui N; Aso T; Kawamoto H; Kurihara H
Radiat Prot Dosimetry; 2015 Mar; 163(4):533-4. PubMed ID: 25227441
[No Abstract] [Full Text] [Related]
19. Feasibility of dosimetry-based high-dose 131I-meta-iodobenzylguanidine with topotecan as a radiosensitizer in children with metastatic neuroblastoma.
Gaze MN; Chang YC; Flux GD; Mairs RJ; Saran FH; Meller ST
Cancer Biother Radiopharm; 2005 Apr; 20(2):195-9. PubMed ID: 15869455
[TBL] [Abstract][Full Text] [Related]
20. Targeted therapy with low doses of 131I-MIBG is effective for disease palliation in highly refractory neuroblastoma.
Weyl Ben-Arush M; Ben Barak A; Bar-Deroma R; Ash S; Goldstein G; Golan H; Houri H; Waldman D; Nevo N; Bar Shalom R; Berniger A; Nevelsky A; Toren A; Yaniv I; Kuten A
Isr Med Assoc J; 2013 Jan; 15(1):31-4. PubMed ID: 23484236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]